🔴 Day 1 Live Update
An engaging presentation by Prof. Kyle H. Rohde on “Halogenated Phenazines Kill Replicating and Dormant Mycobacteria via a Complex Mechanism that Thwarts Resistance Emergence.”
Prof. Rohde is an Associate Professor in the Burnett School of Biomedical Sciences at the University of Central Florida College of Medicine. His research includes pathogenic mycobacteria, including Mycobacterium tuberculosis and Mycobacterium abscessus, with work spanning antibacterial drug discovery, mechanisms of antimicrobial resistance, and related areas of mycobacterial research.
The presentation examines halogenated phenazines and their activity against both replicating and dormant mycobacteria, with particular attention to mechanisms that may limit the emergence of resistance. The topic aligns with ongoing research into new approaches for addressing drug resistance and improving the treatment of difficult-to-treat mycobacterial infections.
Prof. Rohde’s presentation adds to the scientific discussions taking place during Day 1 of Frontiers in TB & Mycobacteriology 2026, covering important areas of tuberculosis research, mycobacterial biology, antimicrobial resistance, and drug discovery.
This conference is organized by Impact Research Communications (IRC)
More info: https://tb.ircconferences.net/ | Frontiers in TB & Mycobacteriology
